Papers
35
Total Citations
841
H-Index
15
About
Jason G. Newman is a leading head and neck surgeon whose research has fundamentally shaped the surgical management of oropharyngeal cancers and advanced the frontier of robotic surgery. His work centers on transoral robotic surgery (TORS), HPV-related oropharyngeal squamous cell carcinoma (OPSCC), and minimally invasive approaches to complex anatomical regions including the skull base and craniocervical junction. Newman's most influential contribution is his leadership of the AVOID trial, a landmark Phase 2 study exploring de-intensification of radiation therapy following TORS for HPV-positive oropharyngeal cancer, now cited over 167 times. This work reflects a broader commitment to reducing treatment morbidity without compromising oncologic outcomes — a critical concern given the rising incidence of HPV-related cancers in younger patients. His early cadaveric and feasibility studies on robotic surgery of the skull base and craniocervical junction, each garnering over 56–68 citations, helped establish TORS as a viable platform far beyond conventional applications. Newman has also made important contributions to identifying risk factors for treatment failure and recurrence in HPV-positive OPSCC, informing adjuvant therapy decisions. His body of work, spanning surgical innovation, clinical oncology, and outcomes research, has meaningfully advanced both the science and practice of minimally invasive head and neck surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Da Vinci Robot-Assisted Transoral Odontoidectomy for Basilar Invagination68 citations · 2010
- 5
- 6Transoral Robotic Surgery of the Skull Base: A Cadaver and Feasibility Study56 citations · 2010
- 7
- 8
- 9
- 10Robotics and Telesurgery in Otolaryngology19 citations · 2011